In a study on AD treatment, it was shown that hyperphosphorylation, which disrupts the function of the tau protein, is regulated by quercetin using mitogen-activated protein kinases and PI3K/Akt/GSK3β signaling pathways. This evidence concerns the gene MAPT and Alzheimer disease.